26001-41-2 Usage
Type
Synthetic compound
Artificially created in a laboratory setting.
Pharmacological properties
Antiviral and anticancer activities
Capable of inhibiting viral replication and growth, as well as potentially stopping or slowing the progression of cancer.
Structure
Methyl group, sugar moiety, and purine ring
Key structural elements that contribute to the compound's biological activity.
Potential applications
Drug candidate for viral infections or cancer treatment
Due to its pharmacological properties, it may be developed into an effective treatment for these conditions.
Further research
Necessary to evaluate pharmacological properties and therapeutic applications
More studies are needed to fully understand the compound's potential and possible uses in medical treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 26001-41-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,0 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 26001-41:
(7*2)+(6*6)+(5*0)+(4*0)+(3*1)+(2*4)+(1*1)=62
62 % 10 = 2
So 26001-41-2 is a valid CAS Registry Number.
26001-41-2Relevant academic research and scientific papers
Synthesis of a peptide nucleic acid with a novel 1-methyl-6-mercaptopurine base
Aboul-Fadl, Tarek,Rajeev, Gopalan,Broom, Arthur D.
, p. 445 - 451 (2008/09/19)
(Chemical Equation Presented) A novel peptide nucleic acid (PNA) monomer 16 containing a novel 1-methyl-6-mercaptopurine base was synthesized by coupling the in situ generated acid chloride of (1-methyl-6-mercaptopurin-9-yl)acetic acid (6) into an L-lysine backbone (13) using 10% CCl4 in pyridine and Ph3P. Compound 6 was synthesized from 6-mercapto-1-methylpurine and ethylbromoacetate in the presence of NaH followed by alkaline hydrolysis and subsequent neutralization with a cation exchange resin. The L-lysine backbone (13) was obtained by the reaction of Nε-CBZ-L-lysine allyl ester with Boc-aminoactaldehyde in the presence of NaBH3CN under reductive amination conditions. Oligomerization of the monomer 16 to PNA analogues was achieved using BOC-BHA-PEG-PS resin as a solid support and the in situ generated acid chloride of 16 by 10% CCl4 in DCM in the presence of Ph 3P.
